Calling big pharma’s bluff

(Dwijen Rangnekar / The Hindu, 3 April 2013) "The lesson from the Supreme Court ruling on Gleevec is that pharmaceutical multinational corporations need to focus research on genuine innovations rather than on ways to evergreen their patents."

www.thehindu.com